Ronald C. McGlennen, M.D.
President & Medical Director
Dr. McGlennen is President and founder of Access Genetics.
He is also Associate Professor of Pathology at the University of Minnesota Medical School. He has published more than 70 scientific articles and book chapters and is the editor of five journals. He holds 9 issued and pending patents. He is board certified in Anatomic and Clinical Pathology and also by the American Board of Medical Genetics, with a Specialty in Clinical Molecular Genetics. He is internationally recognized as an expert in Molecular Biology and Genetics. His focus in research has been on reducing the complexity of gene based testing, including DNA chip technology and simple analytic instrumentation to better serve the community laboratory. He serves on a series of governmental and regulatory committees focused on the growth of the field of molecular diagnostics.
George M. Hoedeman
Chief Executive Officer
Mr. Hoedeman has broad experience in the medical field, and recently was CEO of South Bay Medical and President of the Automation Technology Division of Mentor Corp. He is the former President and CEO of MicroVision and currently serves as the Chairman of Wound Care Technologies, a company he also co-founded. He is co-inventor of the Isoloader™ and IsoStrand™, used with radioisotopes in prostate cancer brachytherapy and the DermaClose™, used for full-depth wound closure. He holds four awarded patents and has four additional pending. He is a Certified Public Accountant (formerly with KPMG), and is an attorney with eight years of experience in private practice. Mr. Hoedeman received his B.A. in accounting from the University of St. Thomas in 1977 and his J.D. from William Mitchell College of Law in 1984.
David J. Olson, M.T., ASCP
Senior Vice President, Product and Laboratory Development
David Olson is a 15-year veteran of the molecular diagnostic field. He has designed and supervised the construction of three laboratory facilities, including labs for the American Red Cross, the University of Minnesota and Esoterix, Inc. Olson is former General Manager of the Esoterix molecular laboratory, and has broad expertise in all aspects of molecular genetics. As a trained medical technologist, he has recognized expertise in the operations of labs, the design of test assays and all other aspects of quality assurance, quality control and regulatory compliance. Olson guides the Access Genetics design team in test and kit development and serves as an Access Genetics on-site laboratory consultant for full service laboratory layout, set-up and hands on customer training.
Robert P. Schuldt
Vice President, Information Technology
Mr. Schuldt is the Vice President of Information Technology at Access Genetics. He brings experience in many areas of computer systems including application development, interfaces, systems infrastructure, and network systems architecture. Prior to joining Access Genetics, he worked in the Internet Technology Center of United Health Care's Advanced Technology Center and designed one of the company's first secure internet applications. He then moved on as a software engineer at the innovative health care software company Abaton.com which was purchased by McKesson in 1999. While at Abaton.com, he specialized in laboratory information systems interfacing and display.
Aaron M. Franks
Vice President, Operations
Aaron Franks has worked for Access Genetics since its inception in June of 2001, starting in research and development, responsible for new test development and has since migrated to the operations department. He brings experience in many areas of operational management from financial analyst to scientist to support specialist. Prior to joining Access Genetics, he spent two years doing genetic research as a Scientist for the Department of Laboratory Medicine and Pathology at the University of Minnesota. Mr. Franks holds an MBA from the Carlson School of Management at the University of Minnesota and received his B.A. from St. Olaf College.